Clinical Trials Browser

Phase 2 × AZD 6244 × Plasma cell × Clear all

NCT01085214 2015-08-19

AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma

Phase 2 Completed

37 enrolled 9 charts

Multiple Myeloma